Report cover image

Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030

Publisher 360iResearch
Published Jun 05, 2024
Length 187 Pages
SKU # IRE18856235

Description

Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030


The Pharmaceutical Manufacturing Market size was estimated at USD 620.68 billion in 2023 and expected to reach USD 672.44 billion in 2024, at a CAGR 8.66% to reach USD 1,110.17 billion by 2030.

Pharmaceutical manufacturing comprises research, development, production, marketing, and distribution of drugs and medicinal products for human use. These products target disease prevention, diagnosis, treatment, and management in various healthcare settings. Key end-users include patients with acute or chronic illnesses, healthcare professionals, clinical trial researchers, insurance companies, and regulatory agencies. Rising aging populations with a higher prevalence of chronic diseases across the globe and increasing need for advanced medicines targeting unmet medical needs influence the growth in the pharmaceutical sector. In addition, rising government funding supports research and development activities in the healthcare sector, allowing new drug development for pharmaceutical companies. However, stringent regulatory requirements imposed by national authorities and the lengthy clinical trial processes create barriers to entry for new pharmaceutical manufacturers.

Moreover, increasing competition from generics and biosimilars and maintaining a robust supply chain pose significant challenges. Furthermore, the technological advancements in drug development processes and a growing focus on personalized medicine create sustainable opportunities for market growth. Also, embracing digital technologies to optimize R&D processes, enhancing the drug development efficiency

Regional Insights

The Americas hold a significant position in the global pharmaceutical market, attributed to its strong research & development (R&D) capabilities, presence of leading pharmaceutical companies, and favorable government policies. The United States has FDA-approved manufacturing facilities focusing on producing biologics and complex generics. European countries, including Germany, France, Switzerland, and the United Kingdom, have advanced pharmaceutical companies with innovative production technologies. These manufacturers have been investing heavily in innovative drug therapies while complying with stringent regulatory standards set by the European Medicines Agency. The Asia Pacific countries initiative aims to boost domestic production and innovation, encouraging investment in R&D and advanced manufacturing technologies. Their policies have led to a surge in new patents filed by pharmaceutical companies. Moreover, the rising investments in healthcare by the private and public sectors in the APAC region fueled the pharmaceutical manufacturing industry.

Market Insights
  • Market Dynamics

    The market dynamics represent an ever-changing landscape of the Pharmaceutical Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
    • Market Drivers
      • Increase in global demand for vaccines and drugs
      • Growing pharmaceutical R&D spending
      • Growth in geriatric population and incidence rate of chronic disorders
      • Market Restraints
        • High costs and complexities associated with the pharma production
        • Market Opportunities
          • Rise in the investment and funding programs in the pharmaceutical manufacturing sector
          • Emergence of novel pharmaceutical manufacturing technologies
          • Market Challenges
            • Stringent government regulations for pharmaceutical companies
            • Market Segmentation Analysis
              • Formulation: Surging investment to support robust research and development of injectable formulations
              • Drug Development Type: Increasing use of outsourced pharmaceutical manufacturing due to its cost effectiveness
              • Route of Administration: Rising research and development activities parenteral drug delivery with rising prevalence of chronic disease
              • Drugs: Inclination toward Over-the-counter (OTC) drugs
              • Age Group: Significant need for drug formulations to treat geriatric medical conditions
              • Distribution Channel: Penetration of non-retail distribution channels for pharmaceuticals
              • Therapy Area: Wave of innovations toward development of new oncology treatment modalities
              • Market Disruption Analysis
              • Porter’s Five Forces Analysis
              • Value Chain & Critical Path Analysis
              • Pricing Analysis
              • Technology Analysis
              • Patent Analysis
              • Trade Analysis
              • Regulatory Framework Analysis
              FPNV Positioning Matrix

              The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pharmaceutical Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

              Market Share Analysis

              The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pharmaceutical Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

              Recent Developments
              • INR 15,000 Crore Proposed in Pharma Sector, India

                The Government of Gujarat, India proposed a significant investment of INR 15,000 crore in pharmaceutical manufacturing. This investment is expected to be made over five years. It aims to establish state-of-the-art infrastructure, attracting major pharmaceutical companies to establish their manufacturing units in the state. This strategic move is projected to generate 1 lakh job opportunities in various fields, including research and development, industrial engineering, production, and logistics.

                Glenmark Pharma Launches Triple-Drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes

                Glenmark Pharmaceuticals Limited, a research-led pharmaceutical company, has introduced Zita DM in India. This innovative formulation incorporates teneligliptin (20mg), dapagliflozin (10mg), and metformin SR (500mg/1000mg). Zita DM is prescribed for patients with type 2 diabetes to enhance glycemic control.

                Novo, Torrent may Widen Tie-Up

                Novo Nordisk India Pvt. Ltd, a pharmaceutical manufacturing company, is considering expanding its partnership opportunities with Torrent Pharmaceuticals Ltd to strengthen its presence in the industry. This decision aims to enhance the company's footprint and solidify its position in the Indian market.
              Strategy Analysis & Recommendation

              The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pharmaceutical Manufacturing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

              Key Company Profiles

              The report delves into recent significant developments in the Pharmaceutical Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Actiza Pharmaceutical Pvt. Ltd., Advent Pharma Ltd., Aenova Group GmbH, Amgen Inc., AstraZeneca PLC, Asymchem, Inc., Azurity Pharmaceuticals, Inc., Bayer AG, Biocon Limited, BioNTech SE, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Limited, Eli Lilly and Company, Emcure Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd., Famar Group, Gilead Sciences, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Lonza Group AG, Lupin Limited, McKesson Corporation, Merck KGaA, Moderna, Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Piramal Pharma Limited, Recipharm AB, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Veranova, L.P., and Zeon Lifesciences Ltd..

              Market Segmentation & Coverage

              This research report categorizes the Pharmaceutical Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
              • Formulation
                • Capsules
                • Injectable
                • Powders
                • Sprays
                • Suspensions
                • Tablets
                • Drug Development Type
                  • In-House
                  • Outsource
                  • Route of Administration
                    • Inhalations
                    • Oral
                    • Parenteral
                    • Topical
                    • Drugs
                      • Over-the-Counter (OTC) Medicines
                      • Prescription Medicines
                      • Age Group
                        • Adults
                        • Children & Adolescents
                        • Geriatric
                        • Distribution Channel
                          • Non-Retail
                          • Retail
                          • Therapy Area
                            • Allergy
                            • Cardiovascular Diseases
                            • Dermatology
                            • Diabetes
                            • Gastroenterology
                            • Infectious Disease
                            • Neurology
                            • Oncology
                            • Ophthalmology
                            • Pain Management
                            • Psychiatry
                            • Pulmonary
                            • Renal Disease
                            • Respiratory Diseases
                            • Region
                              • Americas
                                • Argentina
                                • Brazil
                                • Canada
                                • Mexico
                                • United States
                                  • California
                                  • Florida
                                  • Illinois
                                  • New York
                                  • Ohio
                                  • Pennsylvania
                                  • Texas
                                  • Asia-Pacific
                                    • Australia
                                    • China
                                    • India
                                    • Indonesia
                                    • Japan
                                    • Malaysia
                                    • Philippines
                                    • Singapore
                                    • South Korea
                                    • Taiwan
                                    • Thailand
                                    • Vietnam
                                    • Europe, Middle East & Africa
                                      • Denmark
                                      • Egypt
                                      • Finland
                                      • France
                                      • Germany
                                      • Israel
                                      • Italy
                                      • Netherlands
                                      • Nigeria
                                      • Norway
                                      • Poland
                                      • Qatar
                                      • Russia
                                      • Saudi Arabia
                                      • South Africa
                                      • Spain
                                      • Sweden
                                      • Switzerland
                                      • Turkey
                                      • United Arab Emirates
                                      • United Kingdom


                                      Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

187 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in global demand for vaccines and drugs
5.1.1.2. Growing pharmaceutical R&D spending
5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
5.1.2. Restraints
5.1.2.1. High costs and complexities associated with the pharma production
5.1.3. Opportunities
5.1.3.1. Rise in the investment and funding programs in the pharmaceutical manufacturing sector
5.1.3.2. Emergence of novel pharmaceutical manufacturing technologies
5.1.4. Challenges
5.1.4.1. Stringent government regulations for pharmaceutical companies
5.2. Market Segmentation Analysis
5.2.1. Formulation: Surging investment to support robust research and development of injectable formulations
5.2.2. Drug Development Type: Increasing use of outsourced pharmaceutical manufacturing due to its cost effectiveness
5.2.3. Route of Administration: Rising research and development activities parenteral drug delivery with rising prevalence of chronic disease
5.2.4. Drugs: Inclination toward Over-the-counter (OTC) drugs
5.2.5. Age Group: Significant need for drug formulations to treat geriatric medical conditions
5.2.6. Distribution Channel: Penetration of non-retail distribution channels for pharmaceuticals
5.2.7. Therapy Area: Wave of innovations toward development of new oncology treatment modalities
5.3. Market Trend Analysis
5.3.1. Flourishing pharmaceutical industry and burgeoning pharmaceutical investment & exports in the Americas
5.3.2. Supportive government initiatives and investments for domestic pharmaceutical manufacturing in the Asia-Pacific
5.3.3. Emphasis on R&D of novel drugs and presence of significant pharmaceutical manufacturers in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization
5.8.1. List of Top Selling Prescription and Over-the-Counter Drugs in 2022
6. Pharmaceutical Manufacturing Market, by Formulation
6.1. Introduction
6.2. Capsules
6.3. Injectable
6.4. Powders
6.5. Sprays
6.6. Suspensions
6.7. Tablets
7. Pharmaceutical Manufacturing Market, by Drug Development Type
7.1. Introduction
7.2. In-House
7.3. Outsource
8. Pharmaceutical Manufacturing Market, by Route of Administration
8.1. Introduction
8.2. Inhalations
8.3. Oral
8.4. Parenteral
8.5. Topical
9. Pharmaceutical Manufacturing Market, by Drugs
9.1. Introduction
9.2. Over-the-Counter (OTC) Medicines
9.3. Prescription Medicines
10. Pharmaceutical Manufacturing Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Children & Adolescents
10.4. Geriatric
11. Pharmaceutical Manufacturing Market, by Distribution Channel
11.1. Introduction
11.2. Non-Retail
11.3. Retail
12. Pharmaceutical Manufacturing Market, by Therapy Area
12.1. Introduction
12.2. Allergy
12.3. Cardiovascular Diseases
12.4. Dermatology
12.5. Diabetes
12.6. Gastroenterology
12.7. Infectious Disease
12.8. Neurology
12.9. Oncology
12.10. Ophthalmology
12.11. Pain Management
12.12. Psychiatry
12.13. Pulmonary
12.14. Renal Disease
12.15. Respiratory Diseases
13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. INR 15,000 Crore Proposed in Pharma Sector, India
16.3.2. Glenmark Pharma Launches Triple-Drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes
16.3.3. Novo, Torrent may Widen Tie-Up
16.3.4. U.S. FDA Approves Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
16.3.5. Finnish Manufacturing Facility to Get EUR 50 Million Expansion
16.3.6. Aenova and Galvita Enter Strategic Partnership
16.3.7. Novo Nordisk Invests EUR 2.1 Billion in Hillerød Manufacturing Expansion
16.3.8. Eli Lilly Adds USD 1.6 Billion to its Manufacturing Spending Plan in Indiana
16.3.9. FDA Approves Novartis Millburn Facility for U.S. Commercial Production of Pluvicto
16.3.10. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan
16.3.11. Pfizer Acquires Abzena’s Biologic Manufacturing Facility
17. Competitive Portfolio
17.1. Key Company Profiles
17.2. Key Product Portfolio

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us